Matches in SemOpenAlex for { <https://semopenalex.org/work/W2617998021> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2617998021 abstract "e11023 Background: Evaluation of hormone receptors (ER/PR) and Her2-Neu is important for hormonal and anti-Her2 treatments. The parameters are generally estimated in primary tumors and it is unclear whether re-evaluation of metastatic lesions will be effective during follow-up. Methods: The primary aim of this study was the compare Her2 and HR (ER/PR) status in primary and metastatic tissues of breast cancer patients. HR and Her2 expression in biopsy specimens obtained from primary tumor and their metastatic lesions of 44 breast cancer patients, followed-up during 1995-2010 at Baskent University Hospital were analyzed. Results: Of 44 patients 29.5% were found Her2 (+), 54,5 % ER (+) and 45.4% PR (+) in primary site. Metastatic regions excised or biopsied as following: Bone 31.8% (14/44), liver 27.3% (12/44), skin 25% (11/44), lung 9.1% (4/44), brain 4.5% (2%44), bone marrow 4.5 (2/44), ovaries 4.5% (2/44), stomach, abdominal LAP and pelvic mass 2.3% (3/44). Positification rate of ER status in metastatic sites was detected as 4.5% (2/44), when positive in primary tumors, negatification rate was detected as 20.5%. The positification rate of PR status in metastatic sites, while being negative in primary tissue was 13.6% (6/44); and negativication rate in metastatic lesions, being positive in primary tumor was 27.3% (12/44). The positivication rate of Her2 expression in metastatic lesions while being negative in primary tissue was 4.5% (2/44); and negativication rate while being positive in primary tumor was detected as 13.6% (6/44). When the hormone receptor status and Her2 expression of the patients followed-up are evaluated, receptor variation was detected in 23 of 44 patients. Conclusions: Our study confirms that biological properties of breast cancer may vary among primary tumors and asynchronised metastatic lesions. Further prospective studies are needed to better define the discordance of Her2 or HR status at primary tissue and metastatic sites." @default.
- W2617998021 created "2017-06-05" @default.
- W2617998021 creator A5000442659 @default.
- W2617998021 creator A5019291423 @default.
- W2617998021 creator A5025849285 @default.
- W2617998021 creator A5030366726 @default.
- W2617998021 creator A5042885198 @default.
- W2617998021 creator A5042904223 @default.
- W2617998021 creator A5047643020 @default.
- W2617998021 creator A5060984653 @default.
- W2617998021 creator A5079392781 @default.
- W2617998021 creator A5089639776 @default.
- W2617998021 date "2012-05-20" @default.
- W2617998021 modified "2023-10-01" @default.
- W2617998021 title "Variations at HER2 and hormone receptor status in primary and metastatic sites of breast cancer patients." @default.
- W2617998021 doi "https://doi.org/10.1200/jco.2012.30.15_suppl.e11023" @default.
- W2617998021 hasPublicationYear "2012" @default.
- W2617998021 type Work @default.
- W2617998021 sameAs 2617998021 @default.
- W2617998021 citedByCount "0" @default.
- W2617998021 crossrefType "journal-article" @default.
- W2617998021 hasAuthorship W2617998021A5000442659 @default.
- W2617998021 hasAuthorship W2617998021A5019291423 @default.
- W2617998021 hasAuthorship W2617998021A5025849285 @default.
- W2617998021 hasAuthorship W2617998021A5030366726 @default.
- W2617998021 hasAuthorship W2617998021A5042885198 @default.
- W2617998021 hasAuthorship W2617998021A5042904223 @default.
- W2617998021 hasAuthorship W2617998021A5047643020 @default.
- W2617998021 hasAuthorship W2617998021A5060984653 @default.
- W2617998021 hasAuthorship W2617998021A5079392781 @default.
- W2617998021 hasAuthorship W2617998021A5089639776 @default.
- W2617998021 hasConcept C121608353 @default.
- W2617998021 hasConcept C126322002 @default.
- W2617998021 hasConcept C143998085 @default.
- W2617998021 hasConcept C23589133 @default.
- W2617998021 hasConcept C2775930923 @default.
- W2617998021 hasConcept C530470458 @default.
- W2617998021 hasConcept C71315377 @default.
- W2617998021 hasConcept C71924100 @default.
- W2617998021 hasConceptScore W2617998021C121608353 @default.
- W2617998021 hasConceptScore W2617998021C126322002 @default.
- W2617998021 hasConceptScore W2617998021C143998085 @default.
- W2617998021 hasConceptScore W2617998021C23589133 @default.
- W2617998021 hasConceptScore W2617998021C2775930923 @default.
- W2617998021 hasConceptScore W2617998021C530470458 @default.
- W2617998021 hasConceptScore W2617998021C71315377 @default.
- W2617998021 hasConceptScore W2617998021C71924100 @default.
- W2617998021 hasLocation W26179980211 @default.
- W2617998021 hasOpenAccess W2617998021 @default.
- W2617998021 hasPrimaryLocation W26179980211 @default.
- W2617998021 hasRelatedWork W1488713932 @default.
- W2617998021 hasRelatedWork W152941899 @default.
- W2617998021 hasRelatedWork W1981492719 @default.
- W2617998021 hasRelatedWork W1998872433 @default.
- W2617998021 hasRelatedWork W2003604562 @default.
- W2617998021 hasRelatedWork W2077429944 @default.
- W2617998021 hasRelatedWork W2322218085 @default.
- W2617998021 hasRelatedWork W2562101699 @default.
- W2617998021 hasRelatedWork W2784921575 @default.
- W2617998021 hasRelatedWork W2900202366 @default.
- W2617998021 hasRelatedWork W2939812112 @default.
- W2617998021 hasRelatedWork W2947305228 @default.
- W2617998021 hasRelatedWork W2947992070 @default.
- W2617998021 hasRelatedWork W3012012183 @default.
- W2617998021 hasRelatedWork W3091290297 @default.
- W2617998021 hasRelatedWork W3094421337 @default.
- W2617998021 hasRelatedWork W3132795477 @default.
- W2617998021 hasRelatedWork W3170288793 @default.
- W2617998021 hasRelatedWork W3206111820 @default.
- W2617998021 hasRelatedWork W2953271326 @default.
- W2617998021 isParatext "false" @default.
- W2617998021 isRetracted "false" @default.
- W2617998021 magId "2617998021" @default.
- W2617998021 workType "article" @default.